Literature DB >> 11190616

[The Limberg transposition flap in surgical therapy of chronic pilonidal sinus].

J Jonas1, S Blaich, R Bähr.   

Abstract

The operative treatment of pilonidal sinus is characterized by an increased rate of wound healing complications and late recurrences. The Limberg transposition flap is an easy method for covering the defect after excision of the pilonidal sinus. The flap smooths out the deep skin fold of the rima ani and counteracts in this manner an important pathogenetic factor of pilonidal sinus recurrence. Between 6/96 and 7/99 we treated 42 patients using this method without complications of wound healing or recurrences. Comparison of literature results of different operative treatments (open granulation, primary suture, Z-plasty) shows lessened complication and recurrence rates for the Limberg transposition flap, which is the method of choice for chronic pilonidal sinus nowadays.

Entities:  

Mesh:

Year:  2000        PMID: 11190616     DOI: 10.1055/s-2000-10076

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  4 in total

1.  Karydakis flap for recurrent pilonidal disease.

Authors:  Igors Iesalnieks; Sina Deimel; Hans J Schlitt
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

2.  [Pit-picking surgery for pilonidal disease].

Authors:  I Iesalnieks; S Deimel; K Kienle; H J Schlitt; C Zülke
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

3.  Common surgical procedures in pilonidal sinus disease: A meta-analysis, merged data analysis, and comprehensive study on recurrence.

Authors:  V K Stauffer; M M Luedi; P Kauf; M Schmid; M Diekmann; K Wieferich; B Schnüriger; D Doll
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

4.  Impact of geography and surgical approach on recurrence in global pilonidal sinus disease.

Authors:  Dietrich Doll; Andriu Orlik; Katharina Maier; Peter Kauf; Marco Schmid; Maja Diekmann; Andreas P Vogt; Verena K Stauffer; Markus M Luedi
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.